Michael A Harrington
Overview
Explore the profile of Michael A Harrington including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boyd C, Ananthasekar S, Greene B, Harrington M, King T, Rais-Bahrami S, et al.
Am Surg
. 2021 Mar;
89(11):5036-5037.
PMID: 33710931
No abstract available.
2.
Barnes C, Ford J, Harrington M, Kedar R, Tran T, Karlnoski R, et al.
Plast Reconstr Surg
. 2020 Sep;
146(4):778-781.
PMID: 32969999
Mortality after gluteal augmentation with fat transfer techniques is extremely high. Placement of fat subcutaneously versus in the gluteal musculature, or both, is considerably debated. The purpose of this study...
3.
Boyd C, Inglesby D, Corey B, Greene B, Harrington M, Johnson M, et al.
J Surg Res
. 2020 Jun;
255:96-98.
PMID: 32543384
The COVID-19 pandemic has presented a variety of challenges in the medical education curriculum, one of which is the possible loss of summer and fall away rotations for fourth year...
4.
Weinstein B, King K, Triggs W, Harrington M, Pribaz J
Plast Reconstr Surg
. 2019 Oct;
145(1):231-234.
PMID: 31592948
Perineal reconstruction historically has been guided by the vertical rectus abdominis myocutaneous flap. In oncologic patients, because of prior surgical intervention, this donor site is often unavailable, the pelvis has...
5.
6.
7.
Riccio C, King K, Elston J, Harrington M, Cruse C
Eplasty
. 2016 Dec;
16:ic46.
PMID: 28035248
No abstract available.
8.
Vivar K, Deschaine M, Messina J, Divine J, Rabionet A, Patel N, et al.
J Cutan Pathol
. 2016 Dec;
44(4):381-384.
PMID: 28000240
Nivolumab is a programmed cell death receptor-1 (PD-1) antibody used in the treatment of metastatic or unresectable melanoma. Cutaneous reactions are the most common adverse events reported with these agents...
9.
Glazer E, Porubsky C, Francis J, Ibanez J, Castner N, Messina J, et al.
Ann Plast Surg
. 2016 Dec;
78(6):663-667.
PMID: 27984218
Staged marginal evaluation of melanoma in situ (MIS) is performed to avoid reconstruction on positive margins. Contoured marginal excision (CME) is an excision of a 2-mm wide strip of normal-appearing...
10.
Laun J, Elston J, Harrington M, Payne W
Eplasty
. 2016 Dec;
16:ic44.
PMID: 27980702
No abstract available.